Funds › DME Capital Management, LP
DME Capital Management, LP
13F for Q3 2026, filed Nov 16, 2026. 45 positions worth $3.6B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
$3.6B−$355.6M (9.1%) vs Q2 2026Q3 2026 · filed Nov 16
Latest report
Q3 2026
filed Nov 16, 2026
Reported value
$3.6B
−$355.6M (9.1%) vs Q2 2026
Positions
45
46 in Q2 2026
Top 10 share
52.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Holdings, Q3 2026
Largest first. Common shares only.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | GRBK Green Brick Partners, Inc. | 9.47M | $625.9M | 17.6% | Unchanged | 13F ↗ |
| 2 | FLR Fluor Corporation | 4.61M | $220.6M | 6.2% | -1.1% | 13F ↗ |
| 3 | CNR Core Natural Resources, Inc. · Common Stocks | 2.26M | $193.7M | 5.5% | -1.2% | 13F ↗ |
| 4 | VGNT Versigent PLC | 3.22M | $144.7M | 4.1% | +41.4% | 13F ↗ |
| 5 | BHF Brighthouse Financial, Inc. | 2.84M | $141.8M | 4.0% | Unchanged | 13F ↗ |
| 6 | PCG PG&E Corporation | 10.00M | $122.5M | 3.4% | +50.8% | 13F ↗ |
| 7 | ACHC Acadia Healthcare Company, Inc. | 4.40M | $121.0M | 3.4% | Unchanged | 13F ↗ |
| 8 | CNC Centene Corporation | 1.65M | $102.6M | 2.9% | Unchanged | 13F ↗ |
| 9 | DHT DHT Holdings, Inc. · Common Stocks | 4.28M | $96.6M | 2.7% | -15.0% | 13F ↗ |
| 10 | DCH Dauch Corporation | 18.41M | $96.1M | 2.7% | +48.5% | 13F ↗ |
| 11 | GPK Graphic Packaging Holding Company | 9.95M | $90.1M | 2.5% | Unchanged | 13F ↗ |
| 12 | PENN PENN Entertainment, Inc. | 5.92M | $86.8M | 2.4% | +1.1% | 13F ↗ |
| 13 | FBIN Fortune Brands Innovations, Inc. | 2.28M | $86.6M | 2.4% | +1.5% | 13F ↗ |
| 14 | CENX Century Aluminum Company | 2.27M | $81.7M | 2.3% | New | 13F ↗ |
| 15 | SNX TD SYNNEX Corporation | 313,856 | $80.6M | 2.3% | -17.6% | 13F ↗ |
| 16 | CROX Crocs, Inc. | 653,800 | $76.7M | 2.2% | -2.3% | 13F ↗ |
| 17 | VTRS Viatris Inc. | 4.29M | $76.1M | 2.1% | +54.9% | 13F ↗ |
| 18 | VSNT Versant Media Group, Inc. | 2.28M | $72.1M | 2.0% | +18.4% | 13F ↗ |
| 19 | TEVA Teva Pharmaceutical Industries Limited | 1.82M | $72.0M | 2.0% | New | 13F ↗ |
| 20 | BKV BKV Corporation | 3.32M | $70.9M | 2.0% | +7.3% | 13F ↗ |
| 21 | CPRI Capri Holdings Limited | 4.82M | $68.1M | 1.9% | Unchanged | 13F ↗ |
| 22 | CMCSA Comcast Corporation | 2.82M | $61.4M | 1.7% | +110% | 13F ↗ |
| 23 | HSIC Henry Schein, Inc. | 718,550 | $60.3M | 1.7% | Unchanged | 13F ↗ |
| 24 | SHC Sotera Health Company | 3.24M | $59.9M | 1.7% | -21.6% | 13F ↗ |
| 25 | CNH CNH Industrial N.V. | 4.19M | $53.8M | 1.5% | Unchanged | 13F ↗ |
| 26 | PRMB Primo Brands Corporation · Common Stocks | 2.82M | $53.8M | 1.5% | Unchanged | 13F ↗ |
| 27 | SLG SL Green Realty Corp | 1.06M | $52.0M | 1.5% | New | 13F ↗ |
| 28 | AR Antero Resources Corporation | 1.55M | $51.8M | 1.5% | -1.5% | 13F ↗ |
| 29 | ADIG ADI Global Distribution Inc. | 2.60M | $46.6M | 1.3% | New | 13F ↗ |
| 30 | LBTYA Liberty Global Ltd. Class A | 4.96M | $45.3M | 1.3% | Unchanged | 13F ↗ |
| 31 | ROIV Roivant Sciences Ltd. | 1.13M | $41.4M | 1.2% | -47.4% | 13F ↗ |
| 32 | DECK Deckers Outdoor Corporation | 506,398 | $39.6M | 1.1% | Unchanged | 13F ↗ |
| 33 | BIO Bio-Rad Laboratories, Inc. Class A | 103,990 | $39.3M | 1.1% | New | 13F ↗ |
| 34 | PVH PVH Corp. | 520,800 | $38.6M | 1.1% | Unchanged | 13F ↗ |
| 35 | GLD SPDR Gold Shares · Gold Shs | 92,281 | $35.1M | 1.0% | +10.6% | 13F ↗ |
| 36 | MGM MGM Resorts International | 1.10M | $34.1M | 1.0% | New | 13F ↗ |
| 37 | SLDE Slide Insurance Holdings, Inc. | 1.35M | $30.1M | 0.8% | -20.0% | 13F ↗ |
| 38 | LKQ LKQ Corporation | 1.20M | $27.5M | 0.8% | New | 13F ↗ |
| 39 | CI The Cigna Group | 88,400 | $24.0M | 0.7% | Unchanged | 13F ↗ |
| 40 | LKFT Lakefront Biotherapeutics · ADR | 482,746 | $14.3M | 0.4% | Unchanged | 13F ↗ |
| 41 | COYA Coya Therapeutics, Inc. | 2.34M | $11.7M | 0.3% | Unchanged | 13F ↗ |
| 42 | IMVT Immunovant, Inc. | 70,140 | $2.4M | 0.1% | -25.0% | 13F ↗ |
| 43 | REZI Resideo Technologies, Inc. | 103,277 | $1.9M | 0.1% | -95.8% | 13F ↗ |
| 44 | GANX Gain Therapeutics, Inc. | 566,130 | $979.4K | <0.1% | Unchanged | 13F ↗ |
| 45 | NUVB Nuvation Bio Inc. | 34,995 | $196.0K | <0.1% | Unchanged | 13F ↗ |
Ten largest positions
By value, Q3 2026.
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer